Loading...

Aster DM Healthcare IPO vs Galaxy Surfactants IPO

Comparision between Aster DM Healthcare IPO and Galaxy Surfactants IPO.

IPO Details

Aster DM Healthcare IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Galaxy Surfactants IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Aster DM Healthcare IPO is up to ₹980.14 Cr whereas the issue size of the Galaxy Surfactants IPO is up to ₹937.09 Cr. The final issue price of Aster DM Healthcare IPO is ₹190.00 per share and of Galaxy Surfactants IPO is ₹1,480.00 per share.

  Aster DM Healthcare IPO Galaxy Surfactants IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹180.00 per share ₹1,470.00 per share
Issue Price (Upper) ₹190.00 per share ₹1,480.00 per share
Issue Price (Final) ₹190.00 per share ₹1,480.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 78 shares 10 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹725.00 Cr
OFS Issue Size 1,34,28,251 shares
OFS Issue Size (Amount)
Issue Size Total 63,31,674 shares
Issue Size Total (Amount) up to ₹980.14 Cr up to ₹937.09 Cr

IPO Timetable

Aster DM Healthcare IPO opens on Feb 12, 2018, while Galaxy Surfactants IPO opens on Jan 29, 2018. The closing date of Aster DM Healthcare IPO and Galaxy Surfactants IPO is Feb 15, 2018, and Jan 31, 2018, respectively.

  Aster DM Healthcare IPO Galaxy Surfactants IPO
Anchor Bid Date
Issue Open Feb 12, 2018 Jan 29, 2018
Issue Close Feb 15, 2018 Jan 31, 2018
Basis Of Allotment (Tentative) Feb 22, 2018 Feb 05, 2018
Initiation of Refunds (Tentative) Feb 22, 2018 Feb 06, 2018
Credit of Share (Tentative) Feb 23, 2018 Feb 07, 2018
Listing date (Tentative) Feb 26, 2018 Feb 08, 2018
Anchor Lockin End date 1 Mar 24, 2018 Mar 07, 2018
Anchor Lockin End date 2 May 23, 2018 May 06, 2018

Financials

Aster DM Healthcare IPO P/E ratio is , as compared to Galaxy Surfactants IPO P/E ratio of .

  Aster DM Healthcare IPO Galaxy Surfactants IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (in Rs. million)
31-Mar-17 31-Mar-16 31-Mar-15 (Proforma)
Total Assets 68,072.77 57,557.82 44,120.27
Total Revenue 59,679.02 52,751.63 38,990.49
Profit After Tax 2,667.47 82.11 2,721.07
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (in Rs. million)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 12,853.83 11,092.34 10,602.19 10,240.81 9,556.85
Total Revenue 21,717.00 18,087.55 18,760.26 17,015.78 15,822.68
Profit After Tax 1,463.06 1,027.18 674.56 759.97 2.78
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Aster DM Healthcare IPO retail investors (RII) are offered 1,80,55,151 shares while in Galaxy Surfactants IPO retail investors are offered 1,80,55,151 shares. Qualified institutional buyers (QIB) are offered 1,03,17,229 shares in Aster DM Healthcare IPO and 12,66,336 shares in Galaxy Surfactants IPO.

  Aster DM Healthcare IPO Galaxy Surfactants IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 1,03,17,229 shares 12,66,336 shares
NII 77,37,922 shares 9,49,752 shares
RII 1,80,55,151 shares 22,16,086 shares
Employee
Others
Total 3,61,10,302 shares 44,32,174 shares

Bids Received (Subscription)

Aster DM Healthcare IPO subscribed 1.31x in total, whereas Galaxy Surfactants IPO subscribed 19.96x.

  Aster DM Healthcare IPO Galaxy Surfactants IPO
QIB (times) 2.10x 54.27x
NII (times) 0.55x 6.96x
Big NII (times)
Small NII (times)
RII (times) 1.18x 5.92x
Employee (times)
Other (times)
Total (times) 1.31x 19.96x

Comments

Add a public comment...